{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:15Z","timestamp":1740106935444,"version":"3.37.3"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003069","name":"Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["M2143","M2143"],"award-info":[{"award-number":["M2143","M2143"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00210-023-02753-6","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T11:01:44Z","timestamp":1696417304000},"page":"2159-2170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico identification of a biarylamine acting as agonist at human \u03b23 adrenoceptors and exerting BRL37344-like effects on mouse metabolism"],"prefix":"10.1007","volume":"397","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6529-1502","authenticated-orcid":false,"given":"Marvin A.","family":"Soriano-Urs\u00faa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Antonio","family":"Arias-Monta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Lilia","family":"Ocampo-N\u00e9stor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian F.","family":"Hern\u00e1ndez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Santill\u00e1n-Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Andrade-Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Valdez-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Fern\u00e1ndez-del Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-6489","authenticated-orcid":false,"given":"Jos\u00e9 G.","family":"Trujillo-Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"2753_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00775-021-01915-2","volume":"27","author":"A Abad-Garc\u00eda","year":"2022","unstructured":"Abad-Garc\u00eda A, Ocampo-N\u00e9stor AL, Das BC et al (2022) Interactions of a boron-containing levodopa derivative on D 2 dopamine receptor and its effects in a Parkinson disease model. JBIC J Biol Inorg Chem 27:121\u2013131. https:\/\/doi.org\/10.1007\/s00775-021-01915-2","journal-title":"JBIC J Biol Inorg Chem"},{"key":"2753_CR2","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1007\/s00044-017-1942-6","volume":"26","author":"E Andrade-Jorge","year":"2017","unstructured":"Andrade-Jorge E, Bahena-Herrera JR, Garcia-Gamez J et al (2017) Novel synthesis of isoindoline\/isoindoline-1, 3-dione derivatives under solventless conditions and evaluation with the human D 2 receptor. Med Chem Res 26:2420\u20132431","journal-title":"Med Chem Res"},{"key":"2753_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1007\/s00044-018-2226-5","volume":"27","author":"E Andrade-Jorge","year":"2018","unstructured":"Andrade-Jorge E, S\u00e1nchez-Labastida LA, Soriano-Urs\u00faa MA et al (2018) Isoindolines\/isoindoline-1, 3-diones as AChE inhibitors against Alzheimer\u2019s disease, evaluated by an improved ultra-micro assay. Med Chem Res 27:2187\u20132198. https:\/\/doi.org\/10.1007\/s00044-018-2226-5","journal-title":"Med Chem Res"},{"key":"2753_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","volume":"144","author":"JG Baker","year":"2005","unstructured":"Baker JG (2005) The selectivity of \u03b2-adrenoceptor antagonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors. Br J Pharmacol 144:317\u2013322","journal-title":"Br J Pharmacol"},{"key":"2753_CR5","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1476-5381.2010.00754.x","volume":"160","author":"JG Baker","year":"2010","unstructured":"Baker JG (2010) The selectivity of \u03b2-adrenoceptor agonists at human \u03b21-, \u03b22-and \u03b23-adrenoceptors. Br J Pharmacol 160:1048\u20131061","journal-title":"Br J Pharmacol"},{"key":"2753_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"JA Ballesteros","year":"1995","unstructured":"Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods in Neurosci 25:366\u2013428. https:\/\/doi.org\/10.1016\/S1043-9471(05)80049-7","journal-title":"Methods in Neurosci"},{"key":"2753_CR7","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1111\/febs.15800","volume":"288","author":"LF Barella","year":"2021","unstructured":"Barella LF, Jain S, Kimura T, Pydi SP (2021) Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. FEBS J 288:2622\u20132644","journal-title":"FEBS J"},{"key":"2753_CR8","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.3390\/ijms23063229","volume":"23","author":"M Barr\u00f3n-Gonz\u00e1lez","year":"2022","unstructured":"Barr\u00f3n-Gonz\u00e1lez M, Rosales-Hern\u00e1ndez MC, Abad-Garc\u00eda A et al (2022) Synthesis, in silico, and biological evaluation of a borinic tryptophan-derivative that induces melatonin-like amelioration of cognitive deficit in male rat. Int J Mol Sci 23:3229","journal-title":"Int J Mol Sci"},{"key":"2753_CR9","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2337\/db18-0462","volume":"67","author":"AS Baskin","year":"2018","unstructured":"Baskin AS, Linderman JD, Brychta RJ et al (2018) Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a \u03b23-adrenergic receptor agonist. Diabetes 67:2113\u20132125","journal-title":"Diabetes"},{"key":"2753_CR10","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1074\/jbc.M509966200","volume":"281","author":"CD Bhanumathy","year":"2006","unstructured":"Bhanumathy CD, Nakao SK, Joseph SK (2006) Mechanism of proteasomal degradation of inositol trisphosphate receptors in CHO-K1 cells. J Biol Chem 281:3722\u20133730","journal-title":"J Biol Chem"},{"key":"2753_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1124\/mol.114.092817","volume":"86","author":"H Cernecka","year":"2014","unstructured":"Cernecka H, Sand C, Michel MC (2014) Odd sibling: features of \u03b23-adrenoceptor pharmacology. Mol Pharmacol 86:479\u2013484. https:\/\/doi.org\/10.1124\/mol.114.092817","journal-title":"Mol Pharmacol"},{"key":"2753_CR12","first-page":"518","volume":"8","author":"S Collins","year":"1994","unstructured":"Collins S, Daniel KW, Rohlfs EM et al (1994) Impaired expression and functional activity of the beta 3-and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL\/6J ob\/ob) mice. Mol Endocrinol 8:518\u2013527","journal-title":"Mol Endocrinol"},{"key":"2753_CR13","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2174\/1381612013397339","volume":"7","author":"CJ de Souza","year":"2001","unstructured":"de Souza CJ, Burkey BF (2001) Beta3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm Des 7:1433\u20131449","journal-title":"Curr Pharm Des"},{"key":"2753_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2174\/1570159x17666190409144558","volume":"16","author":"ED Farf\u00e1n-Garc\u00eda","year":"2019","unstructured":"Farf\u00e1n-Garc\u00eda ED, M\u00e1rquez-G\u00f3mez R, Barr\u00f3n-Gonz\u00e1lez M et al (2019) Monoamines and their derivatives on GPCRs: potential therapy for Alzheimer\u2019s disease. Curr Alzheimer Res 16:871\u2013894. https:\/\/doi.org\/10.2174\/1570159x17666190409144558","journal-title":"Curr Alzheimer Res"},{"unstructured":"Frisch MJ, Trucks GW, Schlegel HB et al (2010) Gaussian09 Revision D.01, Gaussian Inc. Wallingford CT. Gaussian 09 Revis. C.01","key":"2753_CR15"},{"key":"2753_CR16","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1021\/acs.jmedchem.6b01601","volume":"60","author":"P Fronik","year":"2017","unstructured":"Fronik P, Gaiser BI, Sejer Pedersen D (2017) Bitopic ligands and metastable binding sites: opportunities for G protein-coupled receptor (GPCR) medicinal chemistry. J Med Chem 60:4126\u20134134","journal-title":"J Med Chem"},{"key":"2753_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0702849","volume":"128","author":"L Gazi","year":"1999","unstructured":"Gazi L, Bobirnac I, Danzeisen M et al (1999) Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4. 4 receptors expressed in CHO cells. Br J Pharmacol 128:613\u2013620","journal-title":"Br J Pharmacol"},{"key":"2753_CR18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2147\/DDDT.S73891","volume":"9","author":"M Ghorbani","year":"2015","unstructured":"Ghorbani M, Teimourian S, Farzad R, Asl NN (2015) Apparent histological changes of adipocytes after treatment with CL 316,243, a \u03b2-3-adrenergic receptor agonist. Drug Des Devel Ther 9:669\u2013676. https:\/\/doi.org\/10.2147\/DDDT.S73891","journal-title":"Drug Des Devel Ther"},{"key":"2753_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser AS, Attwood MM, Rask-Andersen M et al (2017) Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 16:829\u2013842","journal-title":"Nat Rev Drug Discov"},{"key":"2753_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/164_2023_678","volume-title":"Adrenoceptors in the Lower Urinary Tract","author":"M Hennenberg","year":"2023","unstructured":"Hennenberg M, Michel MC (2023) Adrenoceptors in the Lower Urinary Tract. Springer"},{"key":"2753_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41594-017-0011-7","volume":"25","author":"D Hilger","year":"2018","unstructured":"Hilger D, Masureel M, Kobilka BK (2018) Structure and dynamics of GPCR signaling complexes. Nat Struct Mol Biol 25:4\u201312. https:\/\/doi.org\/10.1038\/s41594-017-0011-7","journal-title":"Nat Struct Mol Biol"},{"key":"2753_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Leitz MR, Oberdorf-Maass S et al (2004) Comparative pharmacology of human \u03b2-adrenergic receptor subtypes\u2014characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369:151\u2013159","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2753_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"2753_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1254\/jjp.88.314","volume":"88","author":"M Isogaya","year":"2002","unstructured":"Isogaya M, Nagao T, Kurose H (2002) Enhanced cAMP response of naturally occurring mutant of human \u03b23-adrenergic receptor. Jpn J Pharmacol 88:314\u2013318","journal-title":"Jpn J Pharmacol"},{"key":"2753_CR25","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2131\/jts.35.779","volume":"35","author":"H Kasahara","year":"2010","unstructured":"Kasahara H, Muto S, Motokawa Y et al (2010) \u03b23-adrenoceptor-mediated increased circulating transaminase levels in mice treated with its agonist BRL 37344. J Toxicol Sci 35:779\u2013784","journal-title":"J Toxicol Sci"},{"key":"2753_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fphar.2020.01005","volume":"11","author":"R Kozak","year":"2020","unstructured":"Kozak R, Kiss T, Dlugolenski K et al (2020) Characterization of PF-6142, a novel, non-catecholamine dopamine receptor D1 agonist, in murine and nonhuman primate models of dopaminergic activation. Front Pharmacol 11:1005","journal-title":"Front Pharmacol"},{"key":"2753_CR27","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00210-002-0602-6","volume":"366","author":"Y Kubota","year":"2002","unstructured":"Kubota Y, Nakahara T, Yunoki M et al (2002) Inhibitory mechanism of BRL37344 on muscarinic receptor-mediated contractions of the rat urinary bladder smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 366:198\u2013203","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2753_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acs.jmedchem.6b01453","volume":"61","author":"Y Lee","year":"2018","unstructured":"Lee Y, Basith S, Choi S (2018) Recent advances in structure-based drug design targeting class AG protein-coupled receptors utilizing crystal structures and computational simulations. J Med Chem 61:1\u201346","journal-title":"J Med Chem"},{"key":"2753_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pharmthera.2016.01.007","volume":"159","author":"MC Michel","year":"2016","unstructured":"Michel MC, Korstanje C (2016) \u03b23-adrenoceptor agonists for overactive bladder syndrome: role of translational pharmacology in a repositioning clinical drug development project. Pharmacol Ther 159:66\u201382. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.01.007","journal-title":"Pharmacol Ther"},{"key":"2753_CR30","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791","journal-title":"J Comput Chem."},{"key":"2753_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1124\/jpet.118.249979","volume":"367","author":"A Mossa","year":"2018","unstructured":"Mossa A, Flores MV, Nguyen H et al (2018) Beta-3 adrenoceptor signaling pathways in urothelial and smooth muscle cells in the presence of succinate. J Pharmacol Exp Ther 367:252\u2013259","journal-title":"J Pharmacol Exp Ther"},{"key":"2753_CR32","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1021\/jm4017224","volume":"57","author":"CR Moyes","year":"2014","unstructured":"Moyes CR, Berger R, Goble SD et al (2014) Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective \u03b23 adrenergic receptor agonists for the treatment of overactive bladder. J Med Chem 57:1437\u20131453. https:\/\/doi.org\/10.1021\/jm4017224","journal-title":"J Med Chem"},{"key":"2753_CR33","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.molcel.2021.06.024","volume":"81","author":"C Nagiri","year":"2021","unstructured":"Nagiri C, Kobayashi K, Tomita A et al (2021) Cryo-EM structure of the \u03b23-adrenergic receptor reveals the molecular basis of subtype selectivity. Mol Cell 81:3205\u20133215","journal-title":"Mol Cell"},{"key":"2753_CR34","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1002\/j.1460-2075.1991.tb04940.x","volume":"10","author":"C Nahmias","year":"1991","unstructured":"Nahmias C, Blin N, Elalouf JM et al (1991) Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J 10:3721\u20133727","journal-title":"EMBO J"},{"key":"2753_CR35","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/j.1476-5381.2009.00472.x","volume":"158","author":"RA Ngala","year":"2009","unstructured":"Ngala RA, O\u2019Dowd J, Wang SJ et al (2009) \u03b22-adrenoceptors and non-\u03b2-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice. Br J Pharmacol 158:1676\u20131682","journal-title":"Br J Pharmacol"},{"key":"2753_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbrc.2022.04.065","volume":"611","author":"I Nureki","year":"2022","unstructured":"Nureki I, Kobayashi K, Tanaka T et al (2022) Cryo-EM structures of the \u03b23 adrenergic receptor bound to solabegron and isoproterenol. Biochem Biophys Res Commun 611:158\u2013164. https:\/\/doi.org\/10.1016\/j.bbrc.2022.04.065","journal-title":"Biochem Biophys Res Commun"},{"key":"2753_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11030-018-9883-7","volume":"23","author":"AL Ocampo-N\u00e9stor","year":"2019","unstructured":"Ocampo-N\u00e9stor AL, L\u00f3pez-Mayorga RM, Castillo-Henkel EF et al (2019) Design, synthesis and in vitro evaluation of a Dopa-organoboron compound that acts as a bladder relaxant through non-catecholamine receptors. Mol Divers 23:361\u2013370. https:\/\/doi.org\/10.1007\/s11030-018-9883-7","journal-title":"Mol Divers"},{"key":"2753_CR38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1517\/13543776.2011.561316","volume":"21","author":"MG Perrone","year":"2011","unstructured":"Perrone MG, Scilimati A (2011) \u03b23-adrenoceptor ligand development history through patent review. Expert Opin Ther Pat 21:505\u2013536. https:\/\/doi.org\/10.1517\/13543776.2011.561316","journal-title":"Expert Opin Ther Pat"},{"key":"2753_CR39","doi-asserted-by":"publisher","DOI":"10.1063\/5.0014475","volume":"153","author":"JC Phillips","year":"2020","unstructured":"Phillips JC, Hardy DJ, Maia JDC et al (2020) Scalable molecular dynamics on CPU and GPU architectures with NAMD. J Chem Phys 153:044130. https:\/\/doi.org\/10.1063\/5.0014475","journal-title":"J Chem Phys"},{"key":"2753_CR40","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bcp.2006.11.022","volume":"73","author":"J Ramos-Jim\u00e9nez","year":"2007","unstructured":"Ramos-Jim\u00e9nez J, Soria-Jasso L-E, L\u00f3pez-Colombo A et al (2007) Histamine augments \u03b22-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors. Biochem Pharmacol 73:814\u2013823","journal-title":"Biochem Pharmacol"},{"key":"2753_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","volume":"135","author":"JB Regard","year":"2008","unstructured":"Regard JB, Sato IT, Coughlin SR (2008) Anatomical profiling of G protein-coupled receptor expression. Cell 135:561\u2013571. https:\/\/doi.org\/10.1016\/j.cell.2008.08.040","journal-title":"Cell"},{"key":"2753_CR42","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1210\/clinem\/dgz298","volume":"105","author":"MJ Riis-Vestergaard","year":"2020","unstructured":"Riis-Vestergaard MJ, Richelsen B, Bruun JM et al (2020) Beta-1 and not beta-3 adrenergic receptors may be the primary regulator of human brown adipocyte metabolism. J Clin Endocrinol Metab 105:e994\u2013e1005","journal-title":"J Clin Endocrinol Metab"},{"key":"2753_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1021\/acsmedchemlett.6b00363","volume":"8","author":"D Schmidt","year":"2017","unstructured":"Schmidt D, Gunera J, Baker JG, Kolb P (2017) Similarity-and substructure-based development of \u03b22-adrenergic receptor ligands based on unusual scaffolds. ACS Med Chem Lett 8:481\u2013485","journal-title":"ACS Med Chem Lett"},{"key":"2753_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.tips.2020.12.005","volume":"42","author":"LM Slosky","year":"2021","unstructured":"Slosky LM, Caron MG, Barak LS (2021) Biased allosteric modulators: new Frontiers in GPCR drug discovery. Trends Pharmacol Sci 42:283\u2013299","journal-title":"Trends Pharmacol Sci"},{"key":"2753_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsptsci.0c00024","volume":"3","author":"ME Sommer","year":"2020","unstructured":"Sommer ME, Selent J, Carlsson J et al (2020) The european research network on signal transduction (ernest): toward a multidimensional holistic understanding of g protein-coupled receptor signaling. ACS Pharmacol Transl Sci 3:361\u2013370","journal-title":"ACS Pharmacol Transl Sci"},{"key":"2753_CR46","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bmc.2011.11.054","volume":"20","author":"MA Soriano-Urs\u00faa","year":"2012","unstructured":"Soriano-Urs\u00faa MA, McNaught-Flores DA, Nieto-Alamilla G et al (2012) Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human \u03b22-adrenoceptor. Bioorg Med Chem 20:933\u2013941. https:\/\/doi.org\/10.1016\/j.bmc.2011.11.054","journal-title":"Bioorg Med Chem"},{"key":"2753_CR47","doi-asserted-by":"publisher","first-page":"8207","DOI":"10.1021\/jm400471z","volume":"56","author":"MA Soriano-Urs\u00faa","year":"2013","unstructured":"Soriano-Urs\u00faa MA, Trujillo-Ferrara JG, Correa-Basurto J, Vilar S (2013) Recent structural advances of \u03b21 and \u03b22 adrenoceptors yield keys for ligand recognition and drug design. J Med Chem 56:8207\u20138223","journal-title":"J Med Chem"},{"key":"2753_CR48","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1039\/c5md00011d","volume":"6","author":"MA Soriano-Urs\u00faa","year":"2015","unstructured":"Soriano-Urs\u00faa MA, Trujillo-Ferrara JG, Arias-Monta\u00f1o JA, Villalobos-Molina R (2015) Insights into a defined secondary binding region on \u03b2-adrenoceptors and putative roles in ligand binding and drug design. Medchemcomm 6:991\u20131002. https:\/\/doi.org\/10.1039\/c5md00011d","journal-title":"Medchemcomm"},{"key":"2753_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00249-018-1336-9","volume":"48","author":"MA Soriano-Urs\u00faa","year":"2019","unstructured":"Soriano-Urs\u00faa MA, Bello M, Hern\u00e1ndez-Mart\u00ednez CF et al (2019) Cell-based assays and molecular dynamics analysis of a boron-containing agonist with different profiles of binding to human and Guinea pig beta2 adrenoceptors. Eur Biophys J 48:83\u201397. https:\/\/doi.org\/10.1007\/s00249-018-1336-9","journal-title":"Eur Biophys J"},{"key":"2753_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"B Sun","year":"2021","unstructured":"Sun B, Feng D, Chu ML-H et al (2021) Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist. Nat Commun 12:1\u20139","journal-title":"Nat Commun"},{"key":"2753_CR51","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.106.115840","volume":"321","author":"T Takasu","year":"2007","unstructured":"Takasu T, Ukai M, Sato S et al (2007) Effect of (R)-2-(2-aminothiazol-4-yl)-4\u2032-{2-[(2-hydroxy-2-phenylethyl) amino] ethyl} acetanilide (YM178), a novel selective \u03b23-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321:642\u2013647","journal-title":"J Pharmacol Exp Ther"},{"key":"2753_CR52","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1021\/jm0509445","volume":"49","author":"DE Uehling","year":"2006","unstructured":"Uehling DE, Shearer BG, Donaldson KH et al (2006) Biarylaniline phenethanolamines as potent and selective \u03b23 adrenergic receptor agonists. J Med Chem 49:2758\u20132771","journal-title":"J Med Chem"},{"key":"2753_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153357","volume":"132","author":"JM Valentine","year":"2022","unstructured":"Valentine JM, Ahmadian M, Keinan O et al (2022) \u03b23-adrenergic receptor downregulation leads to adipocyte catecholamine resistance in obesity. J Clin Invest 132:e153357","journal-title":"J Clin Invest"},{"key":"2753_CR54","doi-asserted-by":"publisher","first-page":"6048","DOI":"10.1021\/acs.jmedchem.5b00638","volume":"58","author":"Y Wada","year":"2015","unstructured":"Wada Y, Shirahashi H, Iwanami T et al (2015) Discovery of novel indazole derivatives as highly potent and selective human \u03b23-adrenergic receptor agonists with the possibility of having no cardiovascular side effects. J Med Chem 58:6048\u20136057. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00638","journal-title":"J Med Chem"},{"key":"2753_CR55","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1021\/acs.jmedchem.6b01197","volume":"60","author":"Y Wada","year":"2017","unstructured":"Wada Y, Nakano S, Morimoto A et al (2017) Discovery of novel indazole derivatives as orally available \u03b23-adrenergic receptor agonists lacking off-target-based cardiovascular side effects. J Med Chem 60:3252\u20133265. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01197","journal-title":"J Med Chem"},{"key":"2753_CR56","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S et al (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"key":"2753_CR57","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.tcb.2020.06.002","volume":"30","author":"LM Wingler","year":"2020","unstructured":"Wingler LM, Lefkowitz RJ (2020) Conformational basis of G protein-coupled receptor signaling versatility. Trends Cell Biol 30:736\u2013747","journal-title":"Trends Cell Biol"},{"key":"2753_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113742","volume":"9","author":"C Wu","year":"2014","unstructured":"Wu C, Cheng W, Sun Y et al (2014) Activating brown adipose tissue for weight loss and lowering of blood glucose levels: a microPET study using obese and diabetic model mice. PLoS ONE 9:e113742","journal-title":"PLoS ONE"},{"key":"2753_CR59","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1016\/j.bmc.2010.03.055","volume":"18","author":"H Xiang","year":"2010","unstructured":"Xiang H, Zhao W, Xiao H et al (2010) Synthesis and biological evaluation of isoflavone fatty acid esters with potential weight loss and hypolipidemic activities. Bioorg Med Chem 18:3036\u20133042","journal-title":"Bioorg Med Chem"},{"key":"2753_CR60","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/oby.21124","volume":"23","author":"C Xiao","year":"2015","unstructured":"Xiao C, Goldgof M, Gavrilova O, Reitman ML (2015) Anti-obesity and metabolic efficacy of the \u03b23-adrenergic agonist, CL316243, in mice at thermoneutrality compared to 22\u00b0C. Obesity 23:1450\u20131459. https:\/\/doi.org\/10.1002\/oby.21124","journal-title":"Obesity"},{"key":"2753_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.tem.2006.07.001","volume":"17","author":"K Yasuda","year":"2006","unstructured":"Yasuda K, Matsunaga T, Adachi T et al (2006) Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity. Trends Endocrinol Metab 17:269\u2013275. https:\/\/doi.org\/10.1016\/j.tem.2006.07.001","journal-title":"Trends Endocrinol Metab"},{"key":"2753_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bmcl.2015.11.030","volume":"26","author":"C Zhu","year":"2016","unstructured":"Zhu C, Kar NF, Li B et al (2016) Discovery of benzamides as potent human \u03b23 adrenergic receptor agonists. Bioorganic Med Chem Lett 26:55\u201359. https:\/\/doi.org\/10.1016\/j.bmcl.2015.11.030","journal-title":"Bioorganic Med Chem Lett"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02753-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02753-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T21:25:32Z","timestamp":1710537932000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02753-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2753"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02753-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"20 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments complied with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guide and were conducted in accordance with the guidelines established by the Mexican Secretary of Agriculture and Rural Development (NOM-062-ZOO-1999-SAGARPA) and by the Guide for the Care and Use of Laboratory Animals of the National Research Council. The protocol was approved by the Institutional Committee for the Care of Animals in the Laboratory (CICUAL-06\/26\u201308-2019\u20132.0).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}